June 19, 2013
Kissei Pharmaceutical Co. Ltd. and Actavis Inc. said Monday in virtually identical suits filed in Delaware federal court that Sandoz Inc. and Hetero Labs Ltd. infringed a patent for their enlarged-prostate drug by seeking approval for generic forms of the treatment.